RU2012115039A - METHOD FOR TREATING CHRONIC ENDOMETRITIS - Google Patents
METHOD FOR TREATING CHRONIC ENDOMETRITIS Download PDFInfo
- Publication number
- RU2012115039A RU2012115039A RU2012115039/15A RU2012115039A RU2012115039A RU 2012115039 A RU2012115039 A RU 2012115039A RU 2012115039/15 A RU2012115039/15 A RU 2012115039/15A RU 2012115039 A RU2012115039 A RU 2012115039A RU 2012115039 A RU2012115039 A RU 2012115039A
- Authority
- RU
- Russia
- Prior art keywords
- treating chronic
- days
- chronic endometritis
- day
- cytoflavin
- Prior art date
Links
- 208000030373 chronic endometritis Diseases 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title claims abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract 4
- 239000011780 sodium chloride Substances 0.000 claims abstract 2
- 238000011301 standard therapy Methods 0.000 claims abstract 2
- 238000011287 therapeutic dose Methods 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ лечения хронического эндометрита, включающий стандартную терапию, отличающийся тем, что дополнительно в организм вводят Цитофлавин в терапевтических дозировках 10,0 (20,0) мл на 200,0 (400,0) мл 0,9%-ного раствора натрия хлорида внутривенно капельно 1 раз в сутки в течение 10 дней, затем перорально по 2 таблетки 2 раза в сутки в течение 20 дней.A method of treating chronic endometritis, including standard therapy, characterized in that Cytoflavin is additionally introduced into the body in therapeutic doses of 10.0 (20.0) ml per 200.0 (400.0) ml of a 0.9% sodium chloride solution intravenously drip 1 time per day for 10 days, then 2 tablets orally, 2 times a day for 20 days.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012115039/15A RU2499594C1 (en) | 2012-04-16 | 2012-04-16 | Method of treating chronic endometritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012115039/15A RU2499594C1 (en) | 2012-04-16 | 2012-04-16 | Method of treating chronic endometritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012115039A true RU2012115039A (en) | 2013-10-27 |
| RU2499594C1 RU2499594C1 (en) | 2013-11-27 |
Family
ID=49446182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012115039/15A RU2499594C1 (en) | 2012-04-16 | 2012-04-16 | Method of treating chronic endometritis |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2499594C1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2622024C2 (en) * | 2015-12-01 | 2017-06-08 | Общество с ограниченной ответственностью "Флавимакс" | Application of liposomal dihydroquercetin emulsion "flamena" for treatment of chronic endometritis with autoimmune disorders in case of infertility |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2391104C1 (en) * | 2008-12-29 | 2010-06-10 | Зоя Ивановна Микашинович | Method of treating fetoplacental insufficience |
-
2012
- 2012-04-16 RU RU2012115039/15A patent/RU2499594C1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2499594C1 (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201691151A1 (en) | CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS | |
| MX2022003072A (en) | Use of pridopidine for treating functional decline. | |
| UA114726C2 (en) | 1,4-DISASSEMBLY ANALYSIS OF PIDIDASINE AND METHODS OF TREATMENT OF SMN DEFICIENCES | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| MD4643B1 (en) | Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same | |
| MX2015016421A (en) | Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease. | |
| EP4570314A3 (en) | Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure | |
| AR086422A1 (en) | METHOD FOR THE TREATMENT OF ADVANCED SOLID TUMORS, VOLASERTIB | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| MX2017003780A (en) | PHARMACEUTICAL COMPOSITION TO TREAT ULCERATIVE COLITIS. | |
| MX2015011614A (en) | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy. | |
| MX2016016388A (en) | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds. | |
| EA201591450A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GLYCOSAMINO GLYCAN | |
| CL2016002318A1 (en) | Pharmaceutical composition in the form of a solution comprising a liquid carrier comprising water and between 20% and 95% of one or more alcohols and sildenafil citrate dissolved in said liquid carrier at a concentration of between 7 and 125 mg / ml; methods to obtain it; oral dosage form; oral dosage form; kits | |
| NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
| MX2014014814A (en) | Pharmaceutical composition for treating inflammation and pain. | |
| PH12016501026A1 (en) | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| BR112015005392A2 (en) | tablet formulation of a phosphatidylinositol 3 kinase inhibitor | |
| MX368641B (en) | Compounds for treating inflammation and pain. | |
| RU2014150506A (en) | VELIPARIB IN COMBINATION WITH RADIATION THERAPY OF THE WHOLE BRAIN FOR TREATING METASTASIS IN THE BRAIN | |
| UA71921U (en) | Method for treating toxic neuroretinopathy of alcohol etiology | |
| RU2014142874A (en) | A method of treating a hangover syndrome in persons not related to patients with alcoholism | |
| EA201590325A1 (en) | IMPROVED CANCER TREATMENT WITH REDUCED RENAL TOXICITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140417 |